Peterson Wealth Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35K Sell
150
-17
-10% -$3.93K 0.01% 160
2026
Q2
$35.4K Buy
167
+17
+11% +$3.34K 0.01% 169
2026
Q1
$29.4K Hold
150
– – 0.01% 171
2025
Q4
$26K Sell
150
-60,892
-100% -$11.1M 0.01% 165
2025
Q3
$34.3K Buy
61,042
+60,862
+33,812% +$10.8M 0.01% 167
2025
Q2
$32.3K Hold
180
– – 0.01% 161
2025
Q1
$30.5K Hold
180
– – 0.01% 166
2024
Q4
$27.2K Hold
180
– – 0.01% 171
2024
Q3
$27.9K Buy
+180
New +$26.9K 0.01% 175

Other funds holding DGX

Peterson Wealth Services's DGX Position: Q3 2026 in Review

Peterson Wealth Services reduced its Quest Diagnostics (DGX) stake by 10% in Q3 2026, selling an estimated $3.93K and leaving 150 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #160.

Peterson Wealth Services first reported a position in DGX in Q3 2024 and has held it in 9 quarters since. The position peaked at $35.4K in Q2 2026. 476 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Peterson Wealth Services held 150 shares of Quest Diagnostics worth $35K as of Q3 2026.
  • Peterson Wealth Services sold 17 Quest Diagnostics shares in Q3 2026, an estimated $3.93K.
  • Quest Diagnostics made up 0.01% of Peterson Wealth Services's portfolio in Q3 2026, its #160 holding.
  • Peterson Wealth Services first reported a position in Quest Diagnostics in Q3 2024 and has held it in 9 quarters since.
  • Peterson Wealth Services's Quest Diagnostics position peaked at $35.4K in Q2 2026.
  • 476 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Peterson Wealth Services's 13F filing for Q3 2026, filed 26 Oct 2026.